Crossmark

Molecular assessment of disease states in kidney transplant biopsy samples

Crossref DOI link: https://doi.org/10.1038/nrneph.2016.85

Published Online: 2016-06-27

Published Print: 2016-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Halloran, Philip F.

Famulski, Konrad S.

Reeve, Jeff
License Information

Text and Data Mining valid from 2016-06-27
More Information

Article History

First Online: 27 June 2016

Competing interests

: P.F.H. holds shares in Transcriptome Sciences Inc., a company with an interest in molecular diagnostics in transplantation, and has received research support from Transcriptome Sciences Inc., Roche Molecular Systems, Hoffmann-La Roche Canada Ltd., the Roche Organ Transplant Research Foundation, Novartis Pharma AG, and Astellas. The other authors declare no competing interests.